Description: H&Q Healthcare Investors fund is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated strong market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Healthcare Investors fund was formed on October 31, 1986 and is domiciled in the United States.
Home Page: www.teklacap.com/hqh.html
HQH Technical Analysis
100 Federal Street
Boston,
MA
02110
United States
Phone:
617 772 8500
Officers
| Name | Title |
|---|---|
| Dr. Daniel R. Omstead M.S, Ph.D. | Portfolio Mang. |
| Dr. Jason C. Akus M.B.A., M.D., MBA | VP of Research and Portfolio Mang. |
| Mr. Christopher F. Brinzey MBA | Sr. VP of Research and Portfolio Mang. |
| Dr. Frank T. Gentile Ph.D. | Sr. VP of Research and Portfolio Mang. |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9964 |
| Price-to-Sales TTM: | 107.7871 |
| IPO Date: | 1988-01-05 |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |